Skip to main content
. 2017 Apr 20;7(3):188–197. doi: 10.1159/000462983

Fig. 2.

Fig. 2

Changes in the total ESA dose per week from baseline to 6 and 12 months in the treatment and control groups with a comparison between the 2 groups. * p < 0.0001 versus Pre. p < 0.05 versus ESA dose at the same time point in the control group. ESA, erythropoiesis-stimulating agent; Pre, before treatment.